Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 4378461, 9 pages
http://dx.doi.org/10.1155/2016/4378461
Research Article

Apigenin Attenuates Oxidative Injury in ARPE-19 Cells thorough Activation of Nrf2 Pathway

1Department of Ophthalmology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China
2School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China

Received 11 June 2016; Accepted 1 August 2016

Academic Editor: Ian Copple

Copyright © 2016 Xinrong Xu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Klein and B. E. K. Klein, “The prevalence of age-related eye diseases and visual impairment in aging: current estimates,” Investigative Ophthalmology & Visual Science, vol. 54, no. 14, pp. ORSF5–ORSF13, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. M. A. Zarbin, R. P. Casaroli-Marano, and P. J. Rosenfeld, “Age-related macular degeneration: clinical findings, histopathology and imaging techniques,” Developments in Ophthalmology, vol. 53, pp. 1–32, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Klettner, A. Kauppinen, J. Blasiak, J. Roider, A. Salminen, and K. Kaarniranta, “Cellular and molecular mechanisms of age-related macular degeneration: from impaired autophagy to neovascularization,” The International Journal of Biochemistry & Cell Biology, vol. 45, no. 7, pp. 1457–1497, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. A. G. Smith and P. K. Kaiser, “Emerging treatments for wet age-related macular degeneration,” Expert Opinion on Emerging Drugs, vol. 19, no. 1, pp. 157–164, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Ishikawa, D. Jin, Y. Sawada, S. Abe, and T. Yoshitomi, “Future therapies of wet age-related macular degeneration,” Journal of Ophthalmology, vol. 2015, Article ID 138070, 10 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. P. S. Mettu, A. R. Wielgus, S. S. Ong, and S. W. Cousins, “Retinal pigment epithelium response to oxidant injury in the pathogenesis of early age-related macular degeneration,” Molecular Aspects of Medicine, vol. 33, no. 4, pp. 376–398, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Itoh, J. Mimura, and M. Yamamoto, “Discovery of the negative regulator of Nrf2, Keap1: a historical overview,” Antioxidants & Redox Signaling, vol. 13, no. 11, pp. 1665–1678, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. Z. Zhao, Y. Chen, J. Wang et al., “Age-related retinopathy in NRF2-deficient mice,” PLoS ONE, vol. 6, no. 4, Article ID e19456, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Shukla and S. Gupta, “Apigenin: a promising molecule for cancer prevention,” Pharmaceutical Research, vol. 27, no. 6, pp. 962–978, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. R. H. Patil, R. L. Babu, M. Naveen Kumar et al., “Anti-Inflammatory effect of apigenin on LPS-induced pro-inflammatory mediators and AP-1 factors in human lung epithelial cells,” Inflammation, vol. 39, no. 1, pp. 138–147, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. W. Zhang, H. Qiao, Y. Lv et al., “Apigenin inhibits enterovirus-71 infection by disrupting viral RNA association with trans-acting factors,” PLoS ONE, vol. 9, no. 10, Article ID e110429, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Andueza, A. García-Garzón, M. Ruiz de Galarreta et al., “Oxidation pathways underlying the pro-oxidant effects of apigenin,” Free Radical Biology & Medicine, vol. 87, pp. 169–180, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. T.-H. Tseng, M.-H. Chien, W.-L. Lin et al., “Inhibition of MDA-MB-231 breast cancer cell proliferation and tumor growth by apigenin through induction of G2/M arrest and histone H3 acetylation-mediated p21WAF1/CIP1 expression,” Environmental Toxicology, 2016. View at Publisher · View at Google Scholar
  14. K. C. Dunn, A. E. Aotaki-Keen, F. R. Putkey, and L. M. Hjelmeland, “ARPE-19, a human retinal pigment epithelial cell line with differentiated properties,” Experimental Eye Research, vol. 62, no. 2, pp. 155–169, 1996. View at Publisher · View at Google Scholar · View at Scopus
  15. X.-R. Xu, H.-T. Yu, L. Hang, Y. Shao, S.-H. Ding, and X.-W. Yang, “Preparation of naringenin/β-cyclodextrin complex and its more potent alleviative effect on choroidal neovascularization in rats,” BioMed Research International, vol. 2014, Article ID 623509, 9 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. T. D. Schmittgen, B. A. Zakrajsek, A. G. Mills, V. Gorn, M. J. Singer, and M. W. Reed, “Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods,” Analytical Biochemistry, vol. 285, no. 2, pp. 194–204, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Querques, P. J. Rosenfeld, E. Cavallero et al., “Treatment of dry age-related macular degeneration,” Ophthalmic Research, vol. 52, no. 3, pp. 107–115, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. C. S. Sackett and S. Schenning, “The age-related eye disease study: the results of the clinical trial,” Insight, vol. 27, no. 1, pp. 5–7, 2002. View at Google Scholar · View at Scopus
  19. W. T. Wong, W. Kam, D. Cunningham et al., “Treatment of geographic atrophy by the topical administration of OT-551: results of a phase ii clinical trial,” Investigative Ophthalmology and Visual Science, vol. 51, no. 12, pp. 6131–6139, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. Z. Li, X. Dong, H. Liu et al., “Astaxanthin protects ARPE-19 cells from oxidative stress via upregulation of Nrf2-regulated phase II enzymes through activation of PI3K/AkT,” Molecular Vision, vol. 19, pp. 1656–1666, 2013. View at Google Scholar · View at Scopus
  21. X.-R. Xu, H.-T. Yu, Y. Yang, L. Hang, X.-W. Yang, and S.-H. Ding, “Quercetin phospholipid complex significantly protects against oxidative injury in ARPE-19 cells associated with activation of Nrf2 pathway,” European Journal of Pharmacology, vol. 770, pp. 1–8, 2016. View at Publisher · View at Google Scholar · View at Scopus
  22. X. Paredes-Gonzalez, F. Fuentes, Z.-Y. Su, and A.-N. T. Kong, “Apigenin reactivates Nrf2 anti-oxidative stress signaling in mouse skin epidermal JB6 P + cells through epigenetics modifications,” The AAPS Journal, vol. 16, no. 4, pp. 727–735, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. X. Paredes-Gonzalez, F. Fuentes, S. Jeffery et al., “Induction of NRF2-mediated gene expression by dietary phytochemical flavones apigenin and luteolin,” Biopharmaceutics & Drug Disposition, vol. 36, no. 7, pp. 440–451, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. N. A. Shah, M. R. Khan, B. Ahmad, F. Noureen, U. Rashid, and R. A. Khan, “Investigation on flavonoid composition and anti free radical potential of Sida cordata,” BMC Complementary and Alternative Medicine, vol. 13, article 276, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. Y.-H. Yeh, Y.-L. Hsieh, and Y.-T. Lee, “Effects of yam peel extract against carbon tetrachloride-induced hepatotoxicity in rats,” Journal of Agricultural and Food Chemistry, vol. 61, no. 30, pp. 7387–7396, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Guo, S. Kong, W. Chen et al., “Apigenin mediated protection of OGD-evoked neuron-like injury in differentiated PC12 cells,” Neurochemical Research, vol. 39, no. 11, pp. 2197–2210, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. C.-S. Huang, C.-K. Lii, A.-H. Lin et al., “Protection by chrysin, apigenin, and luteolin against oxidative stress is mediated by the Nrf2-dependent up-regulation of heme oxygenase 1 and glutamate cysteine ligase in rat primary hepatocytes,” Archives of Toxicology, vol. 87, no. 1, pp. 167–178, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. A.-M. Gao, Z.-P. Ke, J.-N. Wang, J.-Y. Yang, S.-Y. Chen, and H. Chen, “Apigenin sensitizes doxorubicin-resistant hepatocellular carcinoma BEL-7402/ADM cells to doxorubicin via inhibiting PI3K/Akt/Nrf2 pathway,” Carcinogenesis, vol. 34, no. 8, pp. 1806–1814, 2013. View at Publisher · View at Google Scholar · View at Scopus